Our Team
ADVANCING TRANSFORMATIVE CARDIOMETABOLIC THERAPEUTICS
Our exceptional team is uniquely suited to execute on our mission of translating our deep understanding of cardiac metabolism into medicines that improve the lives of patients with limited or inadequate treatment options.
Alvin Shih
Chief Executive Officer and Board Member
Albert Kim
Chief Medical Officer
Komal Joshi
Chief Financial Officer
Arash Yavari
Chief Scientific Officer
Sarb Shergill
Senior Vice President, Clinical and Development Operations
Karen Jauregui
Senior Vice President, Regulatory Affairs, Quality and CMC
Vanessa Murray
Senior Director, Clinical Operations
Marcus Hansen
Senior Director, CMC
Sophie Kim
Clinical Trials Manager